The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 07, 2017

Filed:

Jan. 26, 2009
Applicants:

Walter Mier, Bensheim, DE;

Stephan Urban, Neustadt, DE;

Inventors:

Walter Mier, Bensheim, DE;

Stephan Urban, Neustadt, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/29 (2006.01); C07K 7/08 (2006.01); C07K 14/02 (2006.01); A61P 31/20 (2006.01); C07K 14/005 (2006.01); A61K 47/48 (2006.01); A61K 39/12 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/005 (2013.01); A61K 39/12 (2013.01); A61K 39/292 (2013.01); A61K 47/48023 (2013.01); A61K 47/48038 (2013.01); A61K 47/48053 (2013.01); A61K 47/48123 (2013.01); A61K 38/00 (2013.01); C12N 2730/10122 (2013.01); C12N 2730/10134 (2013.01);
Abstract

The present invention relates to hydrophobic modified preS-derived peptides of hepatitis B virus (HBV) which are derived from a HBV preS consensus sequence and are N-terminal preferably acylated and optional C-terminal modified. These hydrophobic modified preS-derived peptides of HBV are very effective HBV entry inhibitors as well as HDV entry inhibitors and are, thus, suitable for the inhibition of HBV and/or HDV infection, prevention of primary HBV and/or HDV infection as well as treatment of (chronic) hepatitis B and/or D. The present invention further relates to pharmaceutical and vaccine compositions comprising these hydrophobic modified preS-derived peptides of HBV.


Find Patent Forward Citations

Loading…